Search the Newsreel

How Medtronic Plc. (MDT) Affects Rotational Strategy Timing

Medtronic Plc. (MDT) shows stable neutral readings in shorter time horizons, potentially signaling an easing of a long-term weak bias, according to Stock Traders Daily's AI analysis. The analysis identifies a mid-channel oscillation pattern and an exceptional 34.3:1 risk-reward setup targeting a 10.0% gain …

Sanara Medtech Inc (SMTI) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Sanara Medtech Inc (SMTI), providing a breakdown of major shareholders including FA Sanara, L.L.C., Tall Pines Capital LLC, and BlackRock Institutional Trust Company, N.A. It also categorizes shareholders by type (e.g., corporation, individual investor) and presents institutional …

Medtronic stock steadies as diabetes and cardiac businesses underpin earnings

Medtronic's stock is stabilizing due to strong performance in its diabetes and cardiovascular segments, which are supporting overall earnings. The company has shown mid-single-digit revenue growth and maintains a healthy operating margin, driven by innovation in areas like insulin delivery systems and minimally invasive …

Sanara Medtech Inc (SMTI) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Sanara Medtech Inc (SMTI) concerning its dividend and stock split history. It states that the company has distributed a total of $0.00 in dividends over the past five years and indicates that there is no historical data available …

Medtronic PLC (MDT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article details the revenue breakdown for Medtronic PLC (MDT) by both business segments and geographical regions. It presents specific financial figures and proportions for categories like Cardiac Rhythm & Heart Failure, Surgical & Endoscopy, and Cranial & Spinal Technologies, as well as revenue …

Sanara Medtech Inc (SMTI) Financial Health: Profitability & Balance Sheet Analysis

Sanara Medtech Inc (SMTI) currently holds a financial score of 7.31, ranking 117 out of 155 in the pharmaceuticals industry, indicating stable financial health and high operating efficiency. The company reported a significant year-over-year revenue increase of 18.62% to $27.80 million, and its net …

Sanara Medtech Inc (SMTI) Institutional Confidence

Sanara Medtech Inc (SMTI) currently holds an institutional shareholding score of 3.00, placing it 92nd out of 155 companies in the Pharmaceuticals industry. The institutional shareholding proportion has increased by 18.63% quarter-over-quarter to 15.50%. James Simons is the largest institutional shareholder, holding 0.71% of …

MDT|Medtronic PLC|Kurs:87.160|Änderung %:+1.240

MDT|Medtronic PLC|Price:82.035|Chg%:+0.145

Medtronic PLC (MDT) shows stable fundamentals and high growth potential, with its valuation considered fairly valued within the Healthcare Equipment & Supplies industry. Analysts largely rate the stock as "Buy" with a target price of $98.22, suggesting an upside of over 19%. The company …

Medtronic Earnings Preview: What to Expect

Medtronic sign seen at its Irvine office_By Tada Images Galway, Ireland-based Medtronic plc (MDT) is a global healthcare technology company that develops and manufactures medical devices, software, and AI-powered solutions to treat more than 70 medical conditions. With a market capitalization of approximately $105.4 …

Medtronic (MDT) Unveils Touch Surgery Aide For Real Time AI In Operating Rooms

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Medtronic (NYSE:MDT) has introduced Touch Surgery Aide, a next generation real-time AI platform designed …

A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Medtronic (NYSE: MDT) is set to unveil Touch Surgery™ Aide, an AI-native surgical computing platform, at the Society of Robotic Surgery 2026 Annual Meeting. This platform, built on NVIDIA infrastructure, enables real-time artificial intelligence during surgical procedures for enhanced decision support and integrates with …

Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors

In the latest close session, Medtronic (MDT) was down 1.13% at $82.35. The stock fell short of the S&P 500, which registered a gain of 0.89% for the day. Elsewhere, the Dow gained 0.74%, while the tech-heavy Nasdaq added 1.29%. Shares of the medical …

Sanara MedTech stock trades steady as advanced wound care growth supports valuation

Sanara MedTech (SMTI) stock trades steadily, backed by robust growth in the advanced wound care sector. The company focuses on specialized products for surgical and chronic wound management within the U.S. healthcare market, showing consistent double-digit revenue expansion and strategic investments in sales and …

Medtronic PLC stock underperforms Tuesday when compared to competitors

Shares of Medtronic PLC (MDT) declined by 1.13% on Tuesday, closing at $82.35. This performance lagged behind the broader market, as the S&P 500 Index and the Dow Jones Industrial Average both saw gains. The stock is currently 22.55% below its 52-week high of …

Medtronic adds real-time AI to Hugo robot

Medtronic has developed a new real-time AI application, Instrument Exit Point (IEP), for its Hugo surgical robot, which has received FDA clearance. This application, running on the Touch Surgery Aide platform with Nvidia's infrastructure, will debut at the Society of Robotic Surgery meeting this …

Trading Systems Reacting to (SMTI) Volatility

This article from July 21, 2026, details how trading systems are reacting to volatility in Sanara Medtech Inc. (NASDAQ: SMTI). It highlights strong near and mid-term sentiment but a weak long-term outlook for the stock. The article provides specific institutional trading strategies, including position, …

Medtronic to announce financial results for its first quarter of fiscal year 2027

GALWAY, Ireland, July 20, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, September 1, 2026, for its first quarter of fiscal year 2027, which ends on Friday, July 31, …

2026 Minnesota ORBIE Awards Recognize Minnesota’s Top Technology and Security Executives

Inspire Leadership Network Leading CIOs and CISOs honored for leadership, innovation, and business impact.Meet the 2026 Minnesota ORBIE Award Winners MINNEAPOLIS, July 20, 2026 (GLOBE NEWSWIRE) -- The 2026 Minnesota ORBIE Awards honored leading chief information officers (CIOs) and chief information security officers (CISOs) …

Medtronic (MDT) to Announce Q1 FY2027 Earnings on August 18

Medtronic (MDT) has announced it will release its financial results for Q1 FY2027 on August 18, 2026. According to GuruFocus, the stock is currently undervalued by 16.5% with a GF Value™ of $99.87 against a current price of $83.44, and holds a solid GF …

Medtronic to report Q1 FY2027 financial results on September 1, 2026

Medtronic plc announced it will release its financial results for the first quarter of fiscal year 2027 on September 1, 2026. The company will issue a news release with summary financial information at 5:45 a.m. Central Time, followed by a video webcast discussion at …

Medtronic sets Sept. 1 date for its next financial report

Medtronic (NYSE: MDT) has announced that it will report its financial results for the first quarter of fiscal year 2027 on Tuesday, September 1, 2026. The report, covering the quarter that ended July 31, 2026, will be released via a news release at 5:45 …

Medtech acquisitions: DePuy Synthes, Medtronic add to portfolios

DePuy Synthes has acquired Expanding Innovations Inc., strengthening its Spine portfolio with expandable implant technology for spine surgery, including the X-PAC TLIF, LLIF, and N-GAGE systems. Concurrently, Medtronic plc completed its acquisition of SPR Therapeutics, valuing it at $650 million, to expand its offerings …

Medtronic and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad

Medtronic and Apollo Hospitals have partnered to open an 11-bed "ICU of the Future" at Apollo Hospitals, Jubilee Hills, Hyderabad. This advanced Intensive Care Unit integrates Medtronic's Acute Care & Monitoring technologies to enhance critical care infrastructure and foster collaboration between clinicians and technology …

Medtronic (MDT) Completes SPR Therapeutics Deal To Expand Non Opioid Pain Care

Medtronic (MDT) has finalized its acquisition of SPR Therapeutics, integrating a minimally invasive, non-opioid pain treatment into its diverse pain therapy portfolio. This strategic move aims to broaden Medtronic's offerings in pain care, particularly in peripheral nerve stimulation, aligning with the growing demand for …

How Medtronic’s (MDT) Targeted Device Recall and Earnings Beat Have Changed Its Investment Story

Medtronic completes $650M acquisition of SPR Therapeutics

Medtronic (NYSE: MDT) has finalized its $650 million acquisition of SPR Therapeutics, a company specializing in short-term peripheral nerve stimulation for pain management. This strategic move strengthens Medtronic's presence in the healthcare equipment industry by integrating SPR's FDA-cleared SPRINT PNS System, a non-opioid, non-surgical …

Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain

Medtronic has completed its acquisition of SPR Therapeutics, Inc. for $650 million, integrating SPR's SPRINT® PNS System into its pain therapy portfolio. This expands Medtronic's offerings for chronic and acute pain management with a minimally invasive, non-opioid treatment that does not require a permanent …

Medtronic Adds 60-Day Pain Therapy Without Permanent Implant

Medtronic (NYSE: MDT) has completed its $650 million cash acquisition of SPR Therapeutics, adding the SPRINT® peripheral nerve stimulation (PNS) technology to its pain therapy portfolio. This acquisition expands Medtronic's offerings for minimally invasive, non-opioid treatments for chronic and acute pain, with clinical data …

Medtronic faces first trial in US hernia mesh injury cases

Medtronic's Covidien unit is facing its first jury trial in Boston over claims that its hernia-repair mesh implants caused injuries. The plaintiff, Larry Patterson, alleges a Symbotex mesh implant led to a bowel obstruction, while Medtronic argues the product worked as designed and other …

SMTI Forecast — Price Target — Prediction for 2027

Medtronic stock holds steady as Q4 FY26 revenue exceeds consensus

Sanara MedTech (SMTI) Posts Modest Gain as Support Holds Steady - MFI Divergence

RedTape FY26 net profit rises 32.4% to ₹244 crore

Earnings Call Transkript: Medtronic übertrifft im vierten Quartal 2026 die Erwartungen bei Umsatz und Gewinn

Redtape Q4 Results: Footwear maker sees 33% revenue growth, margin expands; Stock surges 14%